Commonwealth Equity Services’s Exact Sciences EXAS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | – | Sell |
-38,148
| Closed | -$3.87M | – | 4354 |
|
|
2025
Q4 | $3.87M | Sell |
38,148
-40,158
| -51% | -$3.22M | 0.01% | 1503 |
|
|
2025
Q3 | $4.28M | Buy |
78,306
+313
| +0.4% | +$15.6K | 0.01% | 1460 |
|
|
2025
Q2 | $4.14M | Sell |
77,993
-16,078
| -17% | -$817K | 0.01% | 1453 |
|
|
2025
Q1 | $4.07M | Buy |
94,071
+2,445
| +3% | +$124K | 0.01% | 1413 |
|
|
2024
Q4 | $5.15M | Sell |
91,626
-5,097
| -5% | -$317K | 0.01% | 1218 |
|
|
2024
Q3 | $6.59M | Sell |
96,723
-8,360
| -8% | -$472K | 0.01% | 1051 |
|
|
2024
Q2 | $4.44M | Buy |
105,083
+12,844
| +14% | +$707K | 0.01% | 1263 |
|
|
2024
Q1 | $6.37M | Buy |
92,239
+15,825
| +21% | +$1M | 0.01% | 1028 |
|
|
2023
Q4 | $5.65M | Buy |
76,414
+2,820
| +4% | +$185K | 0.01% | 1035 |
|
|
2023
Q3 | $5.02M | Sell |
73,594
-230
| -0.3% | -$19.5K | 0.01% | 1033 |
|
|
2023
Q2 | $6.93M | Buy |
73,824
+431
| +0.6% | +$33.6K | 0.01% | 864 |
|
|
2023
Q1 | $4.98K | Sell |
73,393
-2,542
| -3% | -$163K | 0.01% | 1008 |
|
|
2022
Q4 | $3.76M | Sell |
75,935
-653
| -0.9% | -$26.7K | 0.01% | 1122 |
|
|
2022
Q3 | $2.49M | Buy |
76,588
+3,174
| +4% | +$131K | 0.01% | 1286 |
|
|
2022
Q2 | $2.89M | Buy |
73,414
+1,618
| +2% | +$86.5K | 0.01% | 1198 |
|
|
2022
Q1 | $5.02M | Sell |
71,796
-2,060
| -3% | -$151K | 0.01% | 944 |
|
|
2021
Q4 | $5.75M | Buy |
73,856
+1,338
| +2% | +$118K | 0.01% | 864 |
|
|
2021
Q3 | $6.92M | Buy |
72,518
+8,097
| +13% | +$855K | 0.02% | 702 |
|
|
2021
Q2 | $8.01M | Buy |
64,421
+11,567
| +22% | +$1.38M | 0.02% | 645 |
|
|
2021
Q1 | $6.96M | Buy |
52,854
+10,707
| +25% | +$1.47M | 0.02% | 634 |
|
|
2020
Q4 | $5.58M | Sell |
42,147
-3,776
| -8% | -$457K | 0.02% | 680 |
|
|
2020
Q3 | $4.68M | Sell |
45,923
-3,070
| -6% | -$265K | 0.02% | 672 |
|
|
2020
Q2 | $4.26M | Buy |
48,993
+95
| +0.2% | +$7.59K | 0.02% | 665 |
|
|
2020
Q1 | $2.84M | Buy |
48,898
+10,272
| +27% | +$834K | 0.01% | 739 |
|
|
2019
Q4 | $3.57M | Buy |
38,626
+11,128
| +40% | +$978K | 0.01% | 743 |
|
|
2019
Q3 | $2.48M | Buy |
27,498
+1,266
| +5% | +$144K | 0.01% | 861 |
|
|
2019
Q2 | $3.1M | Sell |
26,232
-1,376
| -5% | -$139K | 0.01% | 750 |
|
|
2019
Q1 | $2.39M | Buy |
27,608
+349
| +1% | +$29.7K | 0.01% | 846 |
|
|
2018
Q4 | $1.72M | Buy |
27,259
+5,986
| +28% | +$411K | 0.01% | 921 |
|
|
2018
Q3 | $1.68M | Buy |
21,273
+2,193
| +11% | +$143K | 0.01% | 1017 |
|
|
2018
Q2 | $1.14M | Buy |
19,080
+2,731
| +17% | +$147K | 0.01% | 1206 |
|
|
2018
Q1 | $659K | Sell |
16,349
-25
| -0.2% | -$1.22K | ﹤0.01% | 1509 |
|
|
2017
Q4 | $860K | Buy |
16,374
+2,801
| +21% | +$150K | ﹤0.01% | 1321 |
|
|
2017
Q3 | $640K | Sell |
13,573
-4,150
| -23% | -$167K | ﹤0.01% | 1455 |
|
|
2017
Q2 | $627K | Buy |
17,723
+1,501
| +9% | +$46.3K | ﹤0.01% | 1417 |
|
|
2017
Q1 | $383K | Sell |
16,222
-9,911
| -38% | -$196K | ﹤0.01% | 1691 |
|
|
2016
Q4 | $349K | Sell |
26,133
-2,206
| -8% | -$35.6K | ﹤0.01% | 1664 |
|
|
2016
Q3 | $526K | Buy |
28,339
+9,962
| +54% | +$176K | ﹤0.01% | 1351 |
|
|
2016
Q2 | $225K | Sell |
18,377
-1,103
| -6% | -$8.31K | ﹤0.01% | 1877 |
|
|
2016
Q1 | $131K | Sell |
19,480
-1,440
| -7% | -$9.21K | ﹤0.01% | 2021 |
|
|
2015
Q4 | $193K | Sell |
20,920
-8,630
| -29% | -$80.2K | ﹤0.01% | 1888 |
|
|
2015
Q3 | $532K | Sell |
29,550
-2,791
| -9% | -$64.1K | 0.01% | 1209 |
|
|
2015
Q2 | $962K | Buy |
+32,341
| New | +$812K | 0.01% | 982 |
|
Other funds holding EXAS
PRS
PWMAG
IA
HNB
BC
Commonwealth Equity Services's EXAS Position: Q1 2026 in Review
Commonwealth Equity Services sold out of Exact Sciences (EXAS) in Q1 2026, closing a stake of 38,148 shares — an estimated $3.87M sold.
Commonwealth Equity Services first reported a position in EXAS in Q2 2015 and held it in 43 quarters. The position peaked at $8.01M in Q2 2021. 7 funds tracked by Wall St. Rank hold EXAS as of Q1 2026.
- Commonwealth Equity Services reported no remaining Exact Sciences position as of Q1 2026 after selling out during the quarter.
- Commonwealth Equity Services sold 38,148 Exact Sciences shares in Q1 2026, an estimated $3.87M.
- Commonwealth Equity Services first reported a position in Exact Sciences in Q2 2015 and held it in 43 quarters.
- Commonwealth Equity Services's Exact Sciences position peaked at $8.01M in Q2 2021.
- 7 funds tracked by Wall St. Rank held Exact Sciences as of Q1 2026.
Based on Commonwealth Equity Services's 13F filing for Q1 2026, filed 27 Apr 2026.